Position in ABBV
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$102,060,151
+$23,454,916 QoQ
Shares Held
405,580
+12.2% QoQ
Ownership
0.023%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
#251
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026IFM Investors Pty Ltd holds $685,728,678 across 9 Drug Manufacturers - General names. ABBV ranks #3 (14.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
183,394 | $219,968,283 | |
| 2 | JNJ |
Johnson & Johnson
|
559,954 | $142,211,517 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
405,580 | $102,060,151 | |
| 4 | MRK |
Merck & Co., Inc.
|
571,235 | $73,403,697 | |
| 5 | AMGN |
Amgen Inc
|
122,804 | $44,469,784 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
287,894 | $36,372,527 | |
| 7 | PFE |
Pfizer Inc
|
1,334,837 | $32,142,874 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
473,184 | $27,264,862 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $102,060,151 | 405,580 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $78,605,235 | 361,420 | Shares | Sole | 2026-04-24 | |
| 2025-12-31 | $79,836,919 | 349,411 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $79,950,067 | 345,297 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $64,353,897 | 346,697 | Shares | Sole | 2025-07-11 | |
| 2025-03-31 | $70,106,230 | 334,604 | Shares | Sole | 2025-05-21 | |
| 2024-12-31 | $58,794,355 | 330,863 | Shares | Sole | 2025-04-29 | |
| 2024-09-30 | $71,200,229 | 360,544 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $62,060,395 | 361,826 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $65,509,382 | 359,744 | Shares | Sole | 2024-04-22 | |
| 2023-12-31 | $55,958,892 | 361,095 | Shares | Sole | 2024-01-12 | |
| 2023-09-30 | $53,322,190 | 357,723 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $46,751,848 | 347,004 | Shares | Sole | 2023-07-27 | |
| 2023-03-31 | $52,638,157 | 330,289 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $51,822,024 | 320,661 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $41,305,543 | 307,768 | Shares | Sole | 2022-10-12 | |
| 2022-06-30 | $46,698,484 | 304,900 | Shares | Sole | 2022-07-15 | |
| 2022-03-31 | $46,162,929 | 284,763 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $31,848,788 | 235,220 | Shares | Sole | 2022-01-18 | |
| 2021-09-30 | $25,443,189 | 235,869 | Shares | Sole | 2021-10-13 | |
| 2021-06-30 | $26,548,797 | 235,696 | Shares | Sole | 2021-07-16 | |
| 2021-03-31 | $20,920,765 | 193,317 | Shares | Sole | 2021-05-05 | |
| 2020-12-31 | $18,278,289 | 170,586 | Shares | Sole | 2021-01-13 | |
| 2020-09-30 | $12,871,350 | 146,950 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $12,751,127 | 129,875 | Shares | Sole | 2020-07-13 | |
| 2020-03-31 | $11,230,482 | 147,401 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||